 | • レポートコード：QFJ1-3959 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん組織診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫組織化学（IHC）テスト、インサイツハイブリダイゼーションテスト）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん組織診断の市場動向 ・企業の競争状況、市場シェア ・がん組織診断の種類別市場規模と予測2016-2027（免疫組織化学（IHC）テスト、インサイツハイブリダイゼーションテスト） ・がん組織診断の用途別市場規模と予測2016-2027（病院、診療所、その他） ・がん組織診断の北米市場規模2016-2027（アメリカ、カナダ） ・がん組織診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん組織診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん組織診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん組織診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche Ltd.、Danaher Corporation、Thermo Fisher Scientific Inc.、Bio Rad Laboratories Inc.、Abbott、Enzo Life Sciences, Inc.、Agilent Technologies, Inc.、Cancer Genetics Inc.、Merck KGaA (Sigma-Aldrich Co. LLC)、Abcam plc.） ・結論 |
Market Analysis and Insights: Global Cancer Tissue Diagnostics Market
The global Cancer Tissue Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Tissue Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Tissue Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Tissue Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Tissue Diagnostics market.
Global Cancer Tissue Diagnostics Scope and Market Size
Cancer Tissue Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Tissue Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam plc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunohistochemistry (IHC) Test
1.2.3 In Situ Hybridisation Test
1.3 Market by Application
1.3.1 Global Cancer Tissue Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tissue Diagnostics Market Perspective (2016-2027)
2.2 Cancer Tissue Diagnostics Growth Trends by Regions
2.2.1 Cancer Tissue Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Tissue Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Tissue Diagnostics Industry Dynamic
2.3.1 Cancer Tissue Diagnostics Market Trends
2.3.2 Cancer Tissue Diagnostics Market Drivers
2.3.3 Cancer Tissue Diagnostics Market Challenges
2.3.4 Cancer Tissue Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Revenue
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Tissue Diagnostics Revenue
3.4 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2020
3.5 Cancer Tissue Diagnostics Key Players Head office and Area Served
3.6 Key Players Cancer Tissue Diagnostics Product Solution and Service
3.7 Date of Enter into Cancer Tissue Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tissue Diagnostics Breakdown Data by Type
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2022-2027)
5 Cancer Tissue Diagnostics Breakdown Data by Application
5.1 Global Cancer Tissue Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2016-2027)
6.2 North America Cancer Tissue Diagnostics Market Size by Type
6.2.1 North America Cancer Tissue Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Cancer Tissue Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Cancer Tissue Diagnostics Market Size by Type (2016-2027)
6.3 North America Cancer Tissue Diagnostics Market Size by Application
6.3.1 North America Cancer Tissue Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Cancer Tissue Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Cancer Tissue Diagnostics Market Size by Application (2016-2027)
6.4 North America Cancer Tissue Diagnostics Market Size by Country
6.4.1 North America Cancer Tissue Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Cancer Tissue Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2016-2027)
7.2 Europe Cancer Tissue Diagnostics Market Size by Type
7.2.1 Europe Cancer Tissue Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Cancer Tissue Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Cancer Tissue Diagnostics Market Size by Type (2016-2027)
7.3 Europe Cancer Tissue Diagnostics Market Size by Application
7.3.1 Europe Cancer Tissue Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Cancer Tissue Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Cancer Tissue Diagnostics Market Size by Application (2016-2027)
7.4 Europe Cancer Tissue Diagnostics Market Size by Country
7.4.1 Europe Cancer Tissue Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Cancer Tissue Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tissue Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Cancer Tissue Diagnostics Market Size by Type
8.2.1 Asia-Pacific Cancer Tissue Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Tissue Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Application
8.3.1 Asia-Pacific Cancer Tissue Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Tissue Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region
8.4.1 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Tissue Diagnostics Market Size (2016-2027)
9.2 Latin America Cancer Tissue Diagnostics Market Size by Type
9.2.1 Latin America Cancer Tissue Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Tissue Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Tissue Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Cancer Tissue Diagnostics Market Size by Application
9.3.1 Latin America Cancer Tissue Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Tissue Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Tissue Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Cancer Tissue Diagnostics Market Size by Country
9.4.1 Latin America Cancer Tissue Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Tissue Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tissue Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Type
10.2.1 Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Application
10.3.1 Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country
10.4.1 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
11.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Details
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Bio Rad Laboratories Inc.
11.4.1 Bio Rad Laboratories Inc. Company Details
11.4.2 Bio Rad Laboratories Inc. Business Overview
11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
11.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.4.5 Bio Rad Laboratories Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Cancer Tissue Diagnostics Introduction
11.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Details
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 Agilent Technologies, Inc.
11.7.1 Agilent Technologies, Inc. Company Details
11.7.2 Agilent Technologies, Inc. Business Overview
11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
11.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.7.5 Agilent Technologies, Inc. Recent Development
11.8 Cancer Genetics Inc.
11.8.1 Cancer Genetics Inc. Company Details
11.8.2 Cancer Genetics Inc. Business Overview
11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
11.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.8.5 Cancer Genetics Inc. Recent Development
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
11.10 Abcam plc.
11.10.1 Abcam plc. Company Details
11.10.2 Abcam plc. Business Overview
11.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
11.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2016-2021)
11.10.5 Abcam plc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunohistochemistry (IHC) Test
Table 3. Key Players of In Situ Hybridisation Test
Table 4. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cancer Tissue Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Tissue Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cancer Tissue Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Cancer Tissue Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cancer Tissue Diagnostics Market Share by Regions (2022-2027)
Table 10. Cancer Tissue Diagnostics Market Trends
Table 11. Cancer Tissue Diagnostics Market Drivers
Table 12. Cancer Tissue Diagnostics Market Challenges
Table 13. Cancer Tissue Diagnostics Market Restraints
Table 14. Global Cancer Tissue Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cancer Tissue Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tissue Diagnostics as of 2020)
Table 17. Ranking of Global Top Cancer Tissue Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cancer Tissue Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Tissue Diagnostics Product Solution and Service
Table 21. Date of Enter into Cancer Tissue Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cancer Tissue Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cancer Tissue Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cancer Tissue Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cancer Tissue Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Tissue Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cancer Tissue Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cancer Tissue Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cancer Tissue Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cancer Tissue Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cancer Tissue Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cancer Tissue Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cancer Tissue Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Tissue Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Tissue Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cancer Tissue Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Tissue Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cancer Tissue Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Tissue Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cancer Tissue Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd. Company Details
Table 62. F. Hoffmann-La Roche Ltd. Business Overview
Table 63. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product
Table 64. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd. Recent Development
Table 66. Danaher Corporation Company Details
Table 67. Danaher Corporation Business Overview
Table 68. Danaher Corporation Cancer Tissue Diagnostics Product
Table 69. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Danaher Corporation Recent Development
Table 71. Thermo Fisher Scientific Inc. Company Details
Table 72. Thermo Fisher Scientific Inc. Business Overview
Table 73. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product
Table 74. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Thermo Fisher Scientific Inc. Recent Development
Table 76. Bio Rad Laboratories Inc. Company Details
Table 77. Bio Rad Laboratories Inc. Business Overview
Table 78. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product
Table 79. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Bio Rad Laboratories Inc. Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Cancer Tissue Diagnostics Product
Table 84. Abbott Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Enzo Life Sciences, Inc. Company Details
Table 87. Enzo Life Sciences, Inc. Business Overview
Table 88. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product
Table 89. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Enzo Life Sciences, Inc. Recent Development
Table 91. Agilent Technologies, Inc. Company Details
Table 92. Agilent Technologies, Inc. Business Overview
Table 93. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product
Table 94. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Agilent Technologies, Inc. Recent Development
Table 96. Cancer Genetics Inc. Company Details
Table 97. Cancer Genetics Inc. Business Overview
Table 98. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Cancer Genetics Inc. Recent Development
Table 100. Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
Table 101. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
Table 102. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product
Table 103. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
Table 105. Abcam plc. Company Details
Table 106. Abcam plc. Business Overview
Table 107. Abcam plc. Cancer Tissue Diagnostics Product
Table 108. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Abcam plc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tissue Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Immunohistochemistry (IHC) Test Features
Figure 3. In Situ Hybridisation Test Features
Figure 4. Global Cancer Tissue Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Cancer Tissue Diagnostics Report Years Considered
Figure 9. Global Cancer Tissue Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cancer Tissue Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cancer Tissue Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global Cancer Tissue Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global Cancer Tissue Diagnostics Market Share by Players in 2020
Figure 14. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tissue Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2020
Figure 16. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cancer Tissue Diagnostics Market Share by Type (2016-2027)
Figure 20. North America Cancer Tissue Diagnostics Market Share by Application (2016-2027)
Figure 21. North America Cancer Tissue Diagnostics Market Share by Country (2016-2027)
Figure 22. United States Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer Tissue Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe Cancer Tissue Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe Cancer Tissue Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer Tissue Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cancer Tissue Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cancer Tissue Diagnostics Market Share by Region (2016-2027)
Figure 38. China Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer Tissue Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America Cancer Tissue Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America Cancer Tissue Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer Tissue Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cancer Tissue Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cancer Tissue Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cancer Tissue Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 58. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 60. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 62. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 63. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 64. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 65. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 66. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing skin cancer Market Analysis and Insights: Global Skin Cancer Molecular Diagnostics Market The global Skin Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の乳がん再発スコア検査市場規模・現状・予測（2021年-2027年） The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimat…
- 世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
- 世界の結腸直腸癌診断市場規模・現状・予測（2021年-2027年） Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecul…
- 世界の卵巣癌治療＆診断市場規模・現状・予測（2021年-2027年） Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and …